Status:
COMPLETED
Effect of a Protein Intake on Weight Loss of Overweight/Obese Adults
Lead Sponsor:
Clinica Universidad de Navarra, Universidad de Navarra
Conditions:
Obesity
Weight Loss
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
Obesity is considered the epidemic of the 21st century. Obesity is a multifactorial disease and the most important risk factors are poor diet and sedentary lifestyle. An excessive body weight contribu...
Detailed Description
This study is designed as a 12-week, randomised, parallel study, focused on overweight/obese men and women between 20 and 65 years old. All participants attend the Nutrition Intervention Unit of the ...
Eligibility Criteria
Inclusion
- Volunteers with BMI between 24.9 and 34.9 kg/m2.
- Physical examination and vital signs normal or clinically irrelevant to the study.
- Volunteers undergoing pharmacological treatment will be included if the dose is stable for at least 3 months before the start of the study, excluding treatments that alter gastrointestinal function and antidiabetics.
- Subjects must be able to understand and be willing to sign the informed consent, as well as comply with all the procedures and requirements of the study.
- Present a stable weight (+/-3kg) in the last three months before the start of the study.
Exclusion
- Subjects with relevant functional or structural abnormalities of the digestive system, such as malformations, angiodysplasias, active peptic ulcers, chronic inflammatory or malabsorption diseases, hiatal hernia, reflux, etc.
- Subjects with a high alcohol intake, more than 14 units (women) and 20 units (men).
- Women who are breastfeeding or pregnant.
- Subjects who have undergone surgical interventions with permanent sequelae in the digestive system (for example, gastroduodenostomy).
- Subjects with liver disease.
- Subjects with some type of cancer or undergoing treatment for it, or who have not had a period of at least 5 years since its eradication.
- Subjects with allergies to any component of the product under study or any other food that interferes and makes it difficult to monitor the study.
- Subjects who present some type of cognitive and/or psychic impairment.
- Subjects in whom poor collaboration is expected or who, in the opinion of the investigator, have difficulties in following the study procedures.
- Subjects who work night shifts.
- Subjects who follow some type of supplementation that interferes with the study.
- Subjects who are immersed in some treatment for weight loss.
Key Trial Info
Start Date :
January 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT05368311
Start Date
January 13 2022
End Date
August 30 2022
Last Update
May 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Nutrition Research. University of Navarra
Pamplona, Navarre, Spain, 31008